FINWIRES · TerminalLIVE
FINWIRES

調査速報:Hog:EPSは市場予想より1セント低い。2026年の業績見通しは従来通り維持。

By

-- 独立系調査会社CFRAは、に対し、以下の調査レポートを提供しました。CFRAのアナリストは、以下のように見解をまとめています。ハーレーダビッドソン(HOG)の第1四半期EPSは0.22ドルで、市場予想の1.07ドル(79%減)を下回りました。これは、予想を下回る結果です。二輪車事業の売上高は2%減の10億6,000万ドル(市場予想を6,000万ドル上回る)となり、二輪車出荷台数が3%減少したことが主な要因です。同社の伝統的な二輪車事業を担う中核事業であるハーレーダビッドソン・モーター・カンパニー(HDMC)部門は、売上高がわずか2%減にとどまったにもかかわらず、営業利益が84%減の1,900万ドルと大幅に減少しました。この営業レバレッジの悪化は、売上総利益率が390ベーシスポイント低下し25.3%となったことが主な要因です。同社は2026年の業績見通しを維持しており、これは現在の水準からこれ以上の悪化は予想されていないことを示唆しています。火曜日の早朝取引で、HOGの株価は1%上昇した。一部の投資家はHOGが好転するのではないかと期待していたようだが、世界的な二輪車需要の長期的な減少との闘いが続く中、同社には今後も多くの課題が待ち受けていることは明らかだ。

Related Articles

Australia

American Electric Power CEO Says Speed to Market Key Issue in Load Connection

American Electric Power (AEP) CEO Bill Fehrman said Tuesday that speed to market is the main issue in efficiently connecting energy load to generation.In a Q1 earnings call, Fehrman said that, in particular, the performance and stakeholder approval process of PJM, the US mid-Atlantic grid operator, represents a major challenge."The current state of PJM's performance and stakeholder approval process does not give me great confidence that these issues will be resolved any time soon," Fehrman said on the call."In fact, if something is not done now, I expect we could still be having these same conversations in 10 years," he added.Expanding and strengthening the grid will ensure new generation resources can connect quickly, reliably, and affordably to serve the growing load, the CEO said.Price: $137.27, Change: $+2.61, Percent Change: +1.94%

$AEP
Australia

MGE Energy Q1 Earnings, Revenue Rise

MGE Energy (MGEE) reported Q1 earnings Tuesday of $1.32 per diluted share, up from $1.14 a year earlier.One analyst polled by FactSet expected $1.13.Revenue for the three months ended March 31 was $242.7 million, up from $219 million a year earlier.Price: $80.48, Change: $+0.36, Percent Change: +0.46%

$MGEE
Research

Research Alert: CFRA Lowers Rating On Shares Of Pfizer Inc. To Hold From Buy

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our target to $28 from $31, 9.4x our 2027 EPS estimate, below PFE's historical forward P/E average. We keep our 2026 EPS view at $2.99 and our 2027 EPS at $2.97. PFE delivered solid top- and bottom-line Q1 results today that exceeded expectations while demonstrating continued progress in its post-Covid transition strategy. While we continue to think that shares are trading at a discount, as the company's main focus in the next year is on AI integration, and a new transformative M&A is not a key priority, we see limited catalysts to drive meaningful upside potential. We think PFE is aiming to maximize value from launched and acquired products with particular focus on key areas: oncology, obesity/metabolic disease, and vaccines. PFE remains committed to maintaining its dividend, continuing productivity initiatives ($7.2B cost savings target), and pursuing targeted business development (with $7B capacity) but we do not expect PFE executing share buybacks to support the share price in the near term.

$PFE